MedTrace Logo

Exploring Racial Disparities in Sleep Health and Neurocognitive Function

NCT04015830 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-05-10

No results posted yet for this study

Summary

Despite longer life expectancies due to combination antiretroviral therapy (cART), the prevalence of HIV-associated neurocognitive disorders (HAND) persists thus affecting 52% of the HIV population. Poor sleep quality is commonly reported in older adults and has been related to neurocognitive impairments. This is concerning given studies have shown that up to 75% of adults with HIV experience poor sleep, and by 2020, 70% of adults with HIV will be age 50 and older. It is important to examine sleep quality as it relates to neurocognitive function and HAND in older adults with HIV given its negative impact on cART adherence. Compared to Whites with HIV, African Americans (AA) are disproportionately affected by HIV and are more likely to experience poor sleep quality. This primary goal of this 1-year cross-sectional study is to examine racial differences in sleep quality and neurocognitive function among 60 African Americans and Whites with HIV (age 50+).

Conditions

  • HIV Dementia

Interventions

OTHER

electroencephalography (EEG) and event related potentials (ERP)

This is an exploratory study of EEG/ERP measures in older African American and Whites with HIV

Sponsors & Collaborators

  • UAB Resource Centers for Minority Aging Research (RCMAR)

    collaborator UNKNOWN

  • University of Alabama, Tuscaloosa

    lead OTHER

Principal Investigators

  • Shameka L Cody, PhD · The University of Alabama

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-12-01
Completion
2023-01-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04015830 on ClinicalTrials.gov